Cargando…

Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines

OBJECTIVE: Diagnostic delay is high in acromegaly and leads to increased morbidity and mortality. The aim of this study is to systematically assess the most prevalent clinical signs, symptoms and comorbidities of acromegaly at time of diagnosis. DESIGN: A literature search (in PubMed, Embase and Web...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slagboom, Tessa N. A., van Bunderen, Christa C., De Vries, Ralph, Bisschop, Peter H., Drent, Madeleine L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397145/ https://www.ncbi.nlm.nih.gov/pubmed/37210433 http://dx.doi.org/10.1007/s11102-023-01322-7

Ejemplares similares

Impaired neuropsychological functioning in patients with hypopituitarism
por: Slagboom, Tessa N. A., et al.
Publicado: (2020)

Psychological well-being and illness perceptions in patients with hypopituitarism
por: Slagboom, Tessa N. A., et al.
Publicado: (2021)

Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging
por: van Bunderen, Christa C., et al.
Publicado: (2012)

Effect of low-normal and high-normal IGF-1 levels on memory and wellbeing during growth hormone replacement therapy: a randomized clinical trial in adult growth hormone deficiency
por: van Bunderen, Christa C., et al.
Publicado: (2018)

Prevalence of Comorbidities among Patients with Acromegaly
por: Khan, Sajjad Ali, et al.
Publicado: (2021)

Prevalence of comorbidities and associated factors in acromegaly patients in the Turkish population
por: CAN, Mustafa, et al.
Publicado: (2021)

The Pharmacological Burden of Comorbidities in Acromegaly
por: Fleseriu, Maria, et al.
Publicado: (2021)

Titrating Growth Hormone Dose to High-Normal IGF-1 Levels Has Beneficial Effects on Body Fat Distribution and Microcirculatory Function Despite Causing Insulin Resistance
por: van Bunderen, Christa C., et al.
Publicado: (2021)

Prevalence of acromegaly in patients with symptoms of sleep apnea
por: Sesmilo, Gemma, et al.
Publicado: (2017)

Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study
por: Caron, Philippe, et al.
Publicado: (2018)

Management and treatment of ankle sprain according to clinical practice guidelines: A PRISMA systematic review
por: Ruiz-Sánchez, Francisco J., et al.
Publicado: (2022)

Blinded by PRISMA: Are Systematic Reviewers Focusing on PRISMA and Ignoring Other Guidelines?
por: Fleming, Padhraig S., et al.
Publicado: (2014)

Correction to: Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study
por: Caron, Philippe, et al.
Publicado: (2018)

The efficacy of Yiqi Huoxue therapy for chronic heart failure: A meta-analysis in accordance with PRISMA guideline
por: Zhang, Miao, et al.
Publicado: (2022)

Psychotic symptoms in acromegaly
por: Pinto, Denzil, et al.
Publicado: (2005)

The association between BMI and kidney cancer risk: An updated dose-response meta-analysis in accordance with PRISMA guideline
por: Liu, Xuezhen, et al.
Publicado: (2018)

MON-306 Acromegaly Comorbidity Costs, Quality of Life, and Mortality: Lifetime Comparisons for Controlled Acromegaly, Uncontrolled Acromegaly, and the General US Population
por: Whittington, Melanie D, et al.
Publicado: (2020)

Challenges in the diagnosis and management of acromegaly: a focus on comorbidities
por: Abreu, Alin, et al.
Publicado: (2016)

Complications and Comorbidities of Acromegaly—Retrospective Study in Polish Center
por: Rolla, Małgorzata, et al.
Publicado: (2021)

Current state of knowledge on the prevalence of neurodevelopmental disorders in childhood according to the DSM-5: a systematic review in accordance with the PRISMA criteria
por: Francés, Lorena, et al.
Publicado: (2022)

Systematic Reviews: Are They Actually Well Conducted and Reported in Accordance with PRISMA?
por: Gholizadeh, Masoumeh, et al.
Publicado: (2020)

Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States
por: Fleseriu, Maria, et al.
Publicado: (2022)

Systematic reviews and meta-analyses of treatment interventions for Internet use disorders: Critical analysis of the methodical quality according to the PRISMA guidelines
por: Basenach, Lara, et al.
Publicado: (2023)

PRISMA guideline compliance is imperative for systematic review appraisal
por: McKeown, Sandra
Publicado: (2020)

Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly
por: van Trigt, Victoria R., et al.
Publicado: (2021)

Development and evaluation of the Acromegaly Symptom Diary
por: Martin, Susan, et al.
Publicado: (2023)

Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline
por: Giustina, A., et al.
Publicado: (2014)

A Pituitary Society update to acromegaly management guidelines
por: Fleseriu, Maria, et al.
Publicado: (2020)

Association of BMP-14 rs143383 ploymorphism with its susceptibility to osteoarthritis: A meta-analysis and systematic review according to PRISMA guideline
por: Yin, Yi, et al.
Publicado: (2017)

The Relationship between the Burden of Acromegaly, Associated Comorbidities, Complications and Disease Status
por: Elbaum, Michał, et al.
Publicado: (2023)

Prevalence of diabetes mellitus in patients with acromegaly
por: Dreval, A V, et al.
Publicado: (2014)

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
por: Page, Matthew J., et al.
Publicado: (2021)

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
por: Page, Matthew J., et al.
Publicado: (2021)

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
por: Page, Matthew J, et al.
Publicado: (2021)

Discordant biochemical parameters of acromegaly remission do not influence the prevalence or aggressiveness of metabolic comorbidities: a single-center study
por: Romanisio, Martina, et al.
Publicado: (2023)

Quality Reporting of Systematic Review and Meta-Analysis According to PRISMA 2020 Guidelines: Results from Recently Published Papers in the Korean Journal of Radiology
por: Park, Ho Young, et al.
Publicado: (2022)

The efficacy of Yiqi Huoxue method in treating coronary artery disease after percutaneous coronary intervention: A meta-analysis in accordance with PRISMA guideline
por: Zhang, Miao, et al.
Publicado: (2022)

A Comprehensive Review of Four Clinical Practice Guidelines of Acromegaly
por: Ogedegbe, Oboseh J, et al.
Publicado: (2022)

Acromegaly presenting as hirsuitism: Uncommon sinister aetiology of a common clinical sign
por: Jain, Rajesh, et al.
Publicado: (2012)

MON-317 Prognostic Factors and Mortality According to the Structural and Functional Classification of Acromegaly
por: Haro, Andrea Rocha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5c0hqcr66usbcco1rl8qp9f73r